11/6/2024NMPA Accepts AbbVie's BLA for Epcoritamab (Epkinly) for Lymphomas

11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...

11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval

11/4/2024US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA

11/4/2024Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescim...

11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...

11/4/2024CARsgen and Galapagos Resume CAR-T Trials Following Regulatory Pauses

10/31/2024CirCode Advances Gene Therapy with HM2002 IND Approval

10/31/2024AllianThera's IND for IBD Candidate ATB102 Cleared by the USFDA

10/31/2024CStone Announces MHRA Approval of Sugemalimab for First-Line NSCLC Tre...

10/30/2024Zai Lab and BMS Move Toward KarXT Filing in China After Positive Phase...

10/30/2024Innovent Announces Positive Phase 2 Results for Picankibart in Psorias...

10/29/2024Clover Announces Positive Results for RSV Vaccine SCB-1019 vs GSK's AR...

10/28/2024NiKang Presents Discovery of NKT3964, a FIC, Highly Potent and Selecti...

10/28/2024CSPC's BCMA-targeted mRNA-LNP-Based CAR-T SYS6020 Secures New Clinical...

10/28/2024CORXEL and LENZ Therapeutics Announce Positive Topline Data from China...

10/28/2024Beihai Biotech's BEIZRAY® (BH009) Receives FDA Approval for Multiple ...

10/28/2024Akeso's Gumokimab Shows Exceptional Long-Term Efficacy in Phase 3 Psor...

10/24/2024CASI Granted Chinese CTA Approval for CID-103 in Immune Thrombocytope...

10/22/2024Everest Announces Positive Results of Chinese Subpopulation Data from ...

10/21/2024Europe's Share of Global Clinical Trials Shrinks as China Gains Ground...

10/21/2024USFDA Grants Fast Track Designation to Coherent Biopharma's CBP-1008

10/21/2024CStone Announces Patent Publication for First-in-Class ADC CS5006

10/21/2024BeiGene's Secures 14th Indication in China for Tislelizumab

10/21/2024Akeso Launches Phase 1/2 Trial for Novel Bispecific Antibody Combinati...

10/18/2024AstraZeneca Submits Marketing Applications for Tremelimumab and Durval...

10/17/2024Gan & Lee Achieves Primary Endpoints in Phase 2 Trials of Three Diabet...

10/17/2024MSD Files NDA for WINREVAIR (sotatercept) in China

10/16/2024Hengrui Medicine Launches Phase 1/2 Trial for Nectin-4 ADC SHR-A2102 i...

10/16/2024Akeso Launches Phase 1/2 Trial of AK129 and AK117

Page:9/12 Total number of articles:340: [First][<<] [7] [8] [9] [10] [11] [>>] [End]